+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

MinK gene polymorphism in the pathogenesis of lone atrial fibrillation



MinK gene polymorphism in the pathogenesis of lone atrial fibrillation



Kardiologia Polska 64(11): 1205-11; Discussion 1212-3



Atrial fibrillation (AF) is the most common type of complex arrhythmia found in everyday clinical practice. Lone AF is a particular form occurring in 2% to 31% of patients with confirmed AF. Genetic factors may underline this arrhythmia. To determine the relationship between G38S polymorphism in the MinK gene and the incidence of lone AF, and to evaluate this polymorphism as a genetic marker of susceptibility to AF. The study involved 69 patients with lone AF and 60 control healthy subjects. Both groups included patients aged up to 65 years without cardiovascular or thyroid disease. MinK genotype was determined with PCR-RFLP (polymerase chain reaction-restriction fragment length polymorphism). The MinK gene was present in two allelic forms: G and S. The MinK G allele was found significantly more often in patients with AF (62.32%) compared to control subjects (41.80%) (p=0.009). In the AF group GS occurred more frequently (55.07%) than GG (34.78%) and SS genotypes (10.14%). In a logistic regression model the presence of G variant was associated with increase of AF risk in the study population (OR 2.39; 95% CI 0.88-6.54; p=0.084). Presence of GG genotype was associated with significant, over 10-fold, increase of AF risk. Presence of S allele of the MinK gene met criteria of protective factor against AF in the study population. 1. G38S polymorphism in the MinK gene seems to be associated with incidence of lone AF in the study population. 2. GG genotype carrier state may significantly relate to increased risk of AF in the study group. 3. G38S polymorphism in the MinK gene could be used as a genetic marker of risk of lone AF.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 049595469

Download citation: RISBibTeXText

PMID: 17165161


Related references

Association of the human minK gene 38G allele with atrial fibrillation: Evidence of possible genetic control on the pathogenesis of atrial fibrillation. American Heart Journal 144(3): 485-490, September, 2002

Is ACE gene polymorphism associated with lone atrial fibrillation?. Japanese Heart Journal 38(5): 637-641, 1998

Estrogen receptor 1 gene (TA)n polymorphism is associated with lone atrial fibrillation in men. Croatian Medical Journal 55(1): 38-44, 2014

Assessment of interleukin-1 gene cluster polymorphisms in lone atrial fibrillation: new insight into the role of inflammation in atrial fibrillation. Pacing and Clinical Electrophysiology 36(10): 1220-1227, 2014

Mink S38G gene polymorphism and atrial fibrillation in the Chinese population: a meta-analysis of 1871 participants. Thescientificworldjournal 2014: 768681-768681, 2015

ACE I/D polymorphism associated with abnormal atrial and atrioventricular conduction in lone atrial fibrillation and structural heart disease: implications for electrical remodeling. Heart Rhythm 6(9): 1327-1332, 2010

A common polymorphism in SCN5A is associated with lone atrial fibrillation. Clinical Pharmacology and Therapeutics 81(1): 35-41, 2007

Ask the doctor. I'm 64 and have had lone atrial fibrillation for about a decade. I have an echocardiogram every year to make sure the rest of my heart is okay. (It is.) My doctor hasn't prescribed and medications for me, but she wants me to take a blood thinner when I hit my 65th birthday. I'd rather not do this. Should I follow her recommendation? Also, is it possible that the endurance-type exercise regimens I have performed over many years led to my developing lone atrial fibri. Harvard Heart Letter 22(1): 8-8, 2016

A polymorphism associated with increased levels of YKL-40 and the risk of early onset of lone atrial fibrillation. Journal of Negative Results in Biomedicine 12: 1-1, 2013

Effect of atrial pressure increase on effective refractory period and vulnerability to atrial fibrillation in patients with lone atrial fibrillation. Journal of Interventional Cardiac Electrophysiology 3(4): 307-310, 1999

Prolonged atrial effective refractory periods in atrial fibrillation patients associated with structural heart disease or sinus node dysfunction compared with lone atrial fibrillation. Pacing and Clinical Electrophysiology 36(2): 163-171, 2013

Can atrial vulnerability in patients with paroxysmal lone atrial fibrillation predict the development of chronic atrial fibrillation for several years?. European Heart Journal 18(ABSTR SUPPL ): 318, 1997

Different clinical courses and predictors of atrial fibrillation occurrence after transisthmic ablation in patients with preablation lone atrial flutter, coexistent atrial fibrillation, and drug induced atrial flutter. Pacing and Clinical Electrophysiology 27(11): 1507-1512, 2004

Lone atrial fibrillation as a positive predictor of left atrial volume reduction following ablation of atrial fibrillation. Europace 16(1): 26-32, 2014

Polymorphism modulates symptomatic response to antiarrhythmic drug therapy in patients with lone atrial fibrillation. Heart Rhythm 4(6): 743-749, 2007